Sun Min Lim (Sun M Lim)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 22

Top Topics

Squamous Cell Carcinoma

Small Cell Lung Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Therapeutic advances in medical oncology

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Joel W Neal, Nick Pavlakis, Sang-We Kim, Yasushi Goto, Sun Min Lim, Giannis S Mountzios, Elena Fountzilas, Anastasia Mochalova, Daniel C Christoph, Alessandra Bearz, Xavier Quantin, Ramon Palmero, Vladan Antic, Elaine Chun, Tirupathi Rao Edubilli, Ya-Chen Lin, Mahrukh Huseni, Marcus Ballinger, Vilma Graupner, Dominic Curran, Piet Vervaet, Thomas Newsom-Davis
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim, Ying Cheng, Anna R Minchom, Melina E Marmarelis, Rachel E Sanborn, James Chih-Hsin Yang, Baogang Liu, Thomas John, Bartomeu Massuti, Alexander I Spira, Se-Hoon Lee, Jialei Wang, Juan Li, Caigang Liu, Silvia Novello, Masashi Kondo, Motohiro Tamiya, Ernesto Korbenfeld, Mor Moskovitz, Ji-Youn Han, Mariam Alexander, Rohit Joshi, Enriqueta Felip Font, Pei-Jye Voon, Pongwut Danchaivijitr, Ping-Chih Hsu, Felipe José Silva Melo Cruz, Thomas Wehler, Laurent Greillier, Encarnação Teixeira, Danny Nguyen, Joshua K Sabari, Angel Qin, Dariusz Mirosław Kowalski, Mehmet Ali Nahit Şendur, John Xie, Debopriya Ghosh, Ali A Alhadab, Nahor Haddish-Berhane, Pamela L Clemens, Patricia Lorenzini, Remy B Verheijen, Mohamed Gamil, Joshua M Bauml, Mahadi Baig, Antonio Passaro, null null
Subcutaneous versus Intravenous Amivantamab, both in Combination with Lazertinib, in Refractory EGFR -mutated NSCLC: Primary Results from the Phase 3 PALOMA-3 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Moonki Hong, Sang Wook Lee, Byoung Chul Cho, Min Hee Hong, Sun Min Lim, Nak-Jung Kwon
Multiplex analysis for the identification of plasma protein biomarkers for predicting lung cancer immunotherapy response. Therapeutic advances in medical oncology 16 (2024)
Joel W Neal, Nick Pavlakis, Sang-We Kim, Yasushi Goto, Sun Min Lim, Giannis S Mountzios, Elena Fountzilas, Anastasia Mochalova, Daniel C Christoph, Alessandra Bearz, Xavier Quantin, Ramon Palmero, Vladan Antic, Elaine Chun, Tirupathi Rao Edubilli, Ya-Chen Lin, Mahrukh Huseni, Marcus Ballinger, Vilma Graupner, Dominic Curran, Piet Vervaet, Thomas Newsom-Davis
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Eun Ji Lee, Seung Yeon Oh, You Won Lee, Ju Young Kim, Min-Je Kim, Tae Ho Kim, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Anke Baum, Lydia Woelflingseder, Harald Engelhardt, Mark Petronczki, Flavio Solca, Mi Ran Yun, Byoung Chul Cho
Discovery of a novel potent EGFR inhibitor against EGFR activating mutations and on-target resistance in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young Seob Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of immune-modulatory effects of amivantamab in combination with pembrolizumab in lung and head and neck squamous cell carcinoma. Cancer research communications (2024)
Yongsik Sim, Beomseok Sohn, Sooyon Kim, Hye Ryun Kim, Min Hee Hong, Jinna Kim, Seung-Koo Lee, Sun Min Lim
Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma. Future oncology (London, England) (2024)
Su-Jin Choi, Jii Bum Lee, Jae Hwan Kim, Min Hee Hong, Byoung Chul Cho, Sun Min Lim
Analysis of tumor mutational burden and mutational landscape comparing whole-exome sequencing and comprehensive genomic profiling in patients with resectable early-stage non-small-cell lung cancer. Therapeutic advances in medical oncology 16 (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young S Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma. Cancer research communications 4 (7) (2024)
Eun Ji Lee, Seung Yeon Oh, You Won Lee, Ju Young Kim, Min-Je Kim, Tae Ho Kim, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Anke Baum, Lydia Woelflingseder, Harald Engelhardt, Mark Petronczki, Flavio Solca, Mi Ran Yun, Byoung Chul Cho
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young S Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma. Cancer research communications 4 (7) (2024)
Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim, Ying Cheng, Anna R Minchom, Melina E Marmarelis, Rachel E Sanborn, James Chih-Hsin Yang, Baogang Liu, Thomas John, Bartomeu Massuti, Alexander I Spira, Se-Hoon Lee, Jialei Wang, Juan Li, Caigang Liu, Silvia Novello, Masashi Kondo, Motohiro Tamiya, Ernesto Korbenfeld, Mor Moskovitz, Ji-Youn Han, Mariam Alexander, Rohit Joshi, Enriqueta Felip Font, Pei-Jye Voon, Pongwut Danchaivijitr, Ping-Chih Hsu, Felipe José Silva Melo Cruz, Thomas Wehler, Laurent Greillier, Encarnação Teixeira, Danny Nguyen, Joshua K Sabari, Angel Qin, Dariusz Mirosław Kowalski, Mehmet Ali Nahit Şendur, John Xie, Debopriya Ghosh, Ali A Alhadab, Nahor Haddish-Berhane, Pamela L Clemens, Patricia Lorenzini, Remy B Verheijen, Mohamed Gamil, Joshua M Bauml, Mahadi Baig, Antonio Passaro, null null
Subcutaneous versus Intravenous Amivantamab, both in Combination with Lazertinib, in Refractory EGFR -mutated NSCLC: Primary Results from the Phase 3 PALOMA-3 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Joel W Neal, Nick Pavlakis, Sang-We Kim, Yasushi Goto, Sun Min Lim, Giannis S Mountzios, Elena Fountzilas, Anastasia Mochalova, Daniel C Christoph, Alessandra Bearz, Xavier Quantin, Ramon Palmero, Vladan Antic, Elaine Chun, Tirupathi Rao Edubilli, Ya-Chen Lin, Mahrukh Huseni, Marcus Ballinger, Vilma Graupner, Dominic Curran, Piet Vervaet, Thomas Newsom-Davis
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Su-Jin Choi, Jii Bum Lee, Jae Hwan Kim, Min Hee Hong, Byoung Chul Cho, Sun Min Lim
Analysis of tumor mutational burden and mutational landscape comparing whole-exome sequencing and comprehensive genomic profiling in patients with resectable early-stage non-small-cell lung cancer. Therapeutic advances in medical oncology 16 (2024)
Moonki Hong, Sang Wook Lee, Byoung Chul Cho, Min Hee Hong, Sun Min Lim, Nak-Jung Kwon
Multiplex analysis for the identification of plasma protein biomarkers for predicting lung cancer immunotherapy response. Therapeutic advances in medical oncology 16 (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young S Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma. Cancer research communications 4 (7) (2024)
Jing Zhang, Sun Min Lim, Mi Ra Yu, Cheng Chen, Jia Wang, Wenqian Wang, Haopeng Rui, Jingtao Lu, Shun Lu, Tony S K Mok, Zhi Jian Chen, Byoung Chul Cho
D3S-001, a KRAS G12C inhibitor with rapid target engagement kinetics, overcomes nucleotide cycling and demonstrates robust preclinical and clinical activities. Cancer discovery (2024)
Eun Ji Lee, Seung Yeon Oh, You Won Lee, Ju Young Kim, Min-Je Kim, Tae Ho Kim, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Anke Baum, Lydia Woelflingseder, Harald Engelhardt, Mark Petronczki, Flavio Solca, Mi Ran Yun, Byoung Chul Cho
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Sun Min Lim, Solange Peters, Ana Laura Ortega, Gustavo Dix Junqueira Pinto, Christian Sebastián Fuentes, Giuseppe Lo Russo, Michael Schenker, Jin Seok Ahn, Martin Reck, Zsolt Szijgyarto, Neda Huseinovic, Eleftherios Zografos, Elena Buss, Neda Stjepanovic, Sean O'Donnell, Filippo de Marinis
Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial. Nature communications 14 (1) (2023)
Sun Min Lim, Toshio Fujino, Chulwon Kim, Gwanghee Lee, Yong-Hee Lee, Dong Wan Kim, Jin Seok Ahn, Tetsuya Mitsudomi, Taiguang Jin, Sang-Yoon Lee
BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Seung Yeon Oh, You Won Lee, Eun Ji Lee, Seok-Young Kim, Young Joon Park, Seong Gu Heo, Mi Ra Yu, Min Hee Hong, John O DaSilva, Christopher Daly, Byoung Chul Cho, Sun Min Lim, Mi Ran Yun
Preclinical study of a biparatopic METxMET Antibody-Drug Conjugate, REGN5093-M114, overcomes MET-driven acquired resistance to EGFR TKIs in EGFR-mutant NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Chun-Bong Synn, Dong Kwon Kim, Seok-Young Kim, Youngseon Byeon, Young Seob Kim, Mi Ran Yun, Ji Min Lee, Wongeun Lee, Eun Ji Lee, Seul Lee, You Won Lee, Doo Jae Lee, Hyun-Woo Kim, Chang Gon Kim, Min Hee Hong, June Dong Park, Sun Min Lim, Kyoung-Ho Pyo
Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin Tumor. Yonsei medical journal 63 (1) (2021)